-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P7CcYppfZKciFfMHPe21qtBrJNKo0O0SiXFiRKe5z4+z6oWuDSEsSZGKkSUD4fzW CwkbZLYuSHalgX8c2l5jkQ== 0001179110-03-008093.txt : 20030930 0001179110-03-008093.hdr.sgml : 20030930 20030930194000 ACCESSION NUMBER: 0001179110-03-008093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030930 FILED AS OF DATE: 20030930 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WOODGRIFT RANDEL WILLIAM CENTRAL INDEX KEY: 0001204554 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 03918864 BUSINESS ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORP STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EDWARDS LIFESCIENCES CORP CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 edgar.xml FORM 4 - X0201 4 2003-09-30 0 0001099800 EDWARDS LIFESCIENCES CORP EW 0001204554 WOODGRIFT RANDEL WILLIAM C/O EDWARDS LIFESCIENCES CORPORATION; ONE EDWARDS WAY IRVINE CA 92614 0 1 0 0 Corp VP, Manufacturing Ops Employee Stock Option (Right to Acquire) 6.77 2003-09-30 4 A 0 357 0 A 2004-03-30 2013-09-30 Common Stock 357 357 D This option was granted pursuant to the Edwards Lifesciences Corporation Executive Option Plan. The executive officer receives an option in lieu of forgone compensation under a formula where forgone compensation equals 75%, and the exercise price indicated equals 25%, of the fair market value per share on the grant date. The exercise price may be increased to include an additional amount representing the cost of capital as determined by Edwards. The option becomes exercisable six months after the grant date. /s/ Randel W. Woodgrift by Bruce P. Garren as Attorney in Fact pursuant to a Power of Attorney filed with the SEC on October 1, 2002. 2003-09-30 -----END PRIVACY-ENHANCED MESSAGE-----